{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:25:59Z","timestamp":1773797159301,"version":"3.50.1"},"reference-count":88,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bumsuk Academic Research Fund","award":["2020"],"award-info":[{"award-number":["2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Hepatitis B virus (HBV) is a main cause of chronic liver disease worldwide and can lead to severe liver diseases. The World Health Organization has planned to eliminate viral hepatitis, including hepatitis caused by HBV and hepatitis C virus, by 2030. As mother-to-child transmission (MTCT) of HBV is a main cause of chronic HBV infection, MTCT prevention is the main target to reduce the risk of chronic HBV infection and eliminate the disease. Recent clinical trials and meta-analyses found that antiviral therapy could prevent MTCT effectively in mothers with \u2265200,000 IU\/mL of HBV DNA, in combination with serial vaccination and hepatitis B immune globulin administration in infants. Despite the preventive role of antivirals for MTCT of HBV, there are several concerns regarding antiviral therapy with respect to the safety of the mother and fetus during pregnancy. This review summarizes the benefits and risks of antiviral treatment during pregnancy in women with chronic HBV infection.<\/jats:p>","DOI":"10.3390\/jcm10112320","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T10:30:32Z","timestamp":1622025032000},"page":"2320","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B"],"prefix":"10.3390","volume":"10","author":[{"given":"Yoon Seok","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Min","family":"Bang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6396-0859","authenticated-orcid":false,"given":"Young-Sun","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul 08308, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2021, February 14). Global Hepatitis Report. Available online: https:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: Findings from the Global Burden of Disease Study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"Lancet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3350\/cmh.2019.0065","article-title":"Trends in the prevalence of chronic liver disease in the Korean adult population, 1998\u20132017","volume":"26","author":"Park","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: A Lancet Gastroenterology & Hepatology Commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.2.36","article-title":"Natural History and Clinical Consequences of Hepatitis B Virus Infection","volume":"2","author":"Pan","year":"2005","journal-title":"Int. J. Med. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group","volume":"336","author":"Chang","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","article-title":"Two decades of universal hepatitis B vaccination in taiwan: Impact and implication for future strategies","volume":"132","author":"Ni","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J. Viral Hepat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: An Australian experience","volume":"190","author":"Wiseman","year":"2009","journal-title":"Med. J. Aust."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yu, M., Jiang, Q., Gu, X., Ju, L., Ji, Y., Wu, K., and Jiang, H. (2013). Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054246"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.micinf.2013.02.008","article-title":"Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission","volume":"15","author":"Chen","year":"2013","journal-title":"Microbes. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/rmv.1801","article-title":"Mother-to-child transmission of HBV: Review of current clinical management and prevention strategies","volume":"24","author":"Ma","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1478-3231.2008.01933.x","article-title":"Hepatitis B and pregnancy: An underestimated issue","volume":"29","author":"Jonas","year":"2009","journal-title":"Liver Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM197504102921503","article-title":"Vertical transmission of hepatitis B antigen in Taiwan","volume":"292","author":"Stevens","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2013.11.008","article-title":"Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers","volume":"60","author":"Yi","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","article-title":"Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis","volume":"5","author":"Mavilia","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/hep.27034","article-title":"Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11684-014-0340-4","article-title":"Current recommendations of managing HBV infection in preconception or pregnancy","volume":"8","author":"Park","year":"2014","journal-title":"Front. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cgh.2011.10.041","article-title":"An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus","volume":"10","author":"Pan","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/hep.28589","article-title":"Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection","volume":"64","author":"Wen","year":"2016","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2013.02.015","article-title":"Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention","volume":"59","author":"Wen","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(20)30593-4","article-title":"Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: A systematic review and meta-analysis","volume":"21","author":"Boucheron","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM197604012941402","article-title":"e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants","volume":"294","author":"Okada","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.immuni.2016.04.021","article-title":"Offspring\u2019s Tolerance of Mother Goes Viral","volume":"44","author":"Kinder","year":"2016","journal-title":"Immunity"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yang, M., Qin, Q., Fang, Q., Jiang, L., and Nie, S. (2017). Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: A meta-analysis. BMC Pregnancy Childbirth, 17.","DOI":"10.1186\/s12884-017-1487-1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jvh.12032","article-title":"Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women","volume":"20","author":"Guo","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1080\/21645515.2015.1010890","article-title":"An \u201cimmune barrier\u201d is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother","volume":"11","author":"Liu","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(84)92388-2","article-title":"Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study","volume":"1","author":"Wong","year":"1984","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2016.05.048","article-title":"Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer","volume":"151","author":"Chang","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e4390","DOI":"10.1097\/MD.0000000000004390","article-title":"Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00431-006-0327-5","article-title":"Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus","volume":"166","author":"Song","year":"2007","journal-title":"Eur. J. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11901-012-0130-x","article-title":"Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant","volume":"11","author":"Bzowej","year":"2012","journal-title":"Curr. Hepat. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.14218\/JCTH.2016.00014","article-title":"Hepatitis B Management in the Pregnant Patient: An Update","volume":"4","author":"Ayoub","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0033-1345718","article-title":"Antiviral therapy for chronic hepatitis B in pregnancy","volume":"33","author":"Pan","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.28302","article-title":"Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis","volume":"63","author":"Brown","year":"2016","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/hep.28310","article-title":"Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection","volume":"63","author":"Fan","year":"2016","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3748\/wjg.v9.i7.1501","article-title":"Interruption of HBV intrauterine transmission: A clinical study","volume":"9","author":"Li","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection","volume":"55","author":"Han","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Korean Association for the Study of the Liver (KASL) (2019). KASL clinical practice guidelines for management of chronic hepatitis B. Clin. Mol. Hepatol., 25, 93\u2013159.","DOI":"10.3350\/cmh.2019.1002"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load","volume":"374","author":"Pan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1708131","article-title":"Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B","volume":"378","author":"Jourdain","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/apt.14068","article-title":"Systematic review with meta-analysis: The efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus","volume":"45","author":"Hyun","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3904\/kjim.2018.465","article-title":"Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: A systematic review and meta-analysis","volume":"36","author":"Lee","year":"2021","journal-title":"Korean J. Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","article-title":"Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis","volume":"21","author":"Funk","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2006-939758","article-title":"Antiviral drug resistance: Clinical consequences and molecular aspects","volume":"26","author":"Bartholomeusz","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jvh.12212","article-title":"Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations","volume":"21","author":"Ayres","year":"2014","journal-title":"J. Viral Hepat."},{"key":"ref_49","first-page":"115A","article-title":"Tenofovir Alafenamide to prevent perinatal hepatitis B transmission in mothers with high viral load: A multicenter, prospective, observational study","volume":"72","author":"Zeng","year":"2020","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol., 67, 370\u2013398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5009\/gnl15562","article-title":"Management of Antiviral Resistance in Chronic Hepatitis B","volume":"11","author":"Lim","year":"2017","journal-title":"Gut Liver"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Cathcart, A.L., Chan, H.L., Bhardwaj, N., Liu, Y., Marcellin, P., Pan, C.Q., Buti, M., Cox, S., and Parhy, B. (2018). No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.01064-18"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0b013e3181e45951","article-title":"Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: A systematic review and meta-analysis","volume":"116","author":"Shi","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/liv.12959","article-title":"Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: A network meta-analysis","volume":"36","author":"Njei","year":"2016","journal-title":"Liver Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3748\/wjg.v17.i38.4321","article-title":"A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus","volume":"17","author":"Han","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7754\/Clin.Lab.2013.130408","article-title":"Telbivudine during the second and third trimester of pregnancy interrupts HBV intrauterine transmission: A systematic review and meta-analysis","volume":"60","author":"Lu","year":"2014","journal-title":"Clin. Lab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5144\/0256-4947.2013.169","article-title":"Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: A meta-analysis","volume":"33","author":"Liu","year":"2013","journal-title":"Ann. Saudi Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1743-422X-9-185","article-title":"The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: A systematic review and meta-analysis","volume":"9","author":"Deng","year":"2012","journal-title":"Virol. J."},{"key":"ref_59","unstructured":"The Antiretroviral Pregnancy Registry (2021, May 05). Interim Report. 1 January 1989 through 31 July 2020. Available online: http:\/\/www.apregistry.com\/forms\/interim_report.pdf."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"F241","DOI":"10.1097\/00002030-199818000-00002","article-title":"Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study","volume":"12","author":"Lorenzi","year":"1998","journal-title":"AIDS"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3350\/cmh.2018.0106","article-title":"Unmet need in chronic hepatitis B management","volume":"25","author":"Liang","year":"2019","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/cid\/civ437","article-title":"Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0b013e328358ccaa","article-title":"Blunted fetal growth by tenofovir in late pregnancy","volume":"26","author":"Kinai","year":"2012","journal-title":"AIDS"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41575-020-00361-w","article-title":"Viral hepatitis and pregnancy","volume":"18","author":"Terrault","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1478-3231.2009.02153.x","article-title":"The outcomes of pregnancy in patients with cirrhosis: A population-based study","volume":"30","author":"Shaheen","year":"2010","journal-title":"Liver Int."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/hiv.12120","article-title":"Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV","volume":"15","author":"Mave","year":"2014","journal-title":"HIV Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.178.6.3345","article-title":"Maternal acceptance of the fetus: True human tolerance","volume":"178","author":"Guleria","year":"2007","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2893.2007.00894.x","article-title":"Exacerbation of chronic hepatitis B infection after delivery","volume":"15","author":"Leemans","year":"2008","journal-title":"J. Viral Hepat."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/apt.12726","article-title":"Anti-viral therapy for prevention of perinatal HBV transmission: Extending therapy beyond birth does not protect against post-partum flare","volume":"39","author":"Nguyen","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1002\/hep.22885","article-title":"Side effects of long-term oral antiviral therapy for hepatitis B","volume":"49","author":"Fontana","year":"2009","journal-title":"Hepatology"},{"key":"ref_74","first-page":"713","article-title":"The New Pregnancy and Lactation Labeling Rule","volume":"41","author":"Pernia","year":"2016","journal-title":"Phys. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2019.07.023","article-title":"Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage","volume":"87","author":"Hu","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/cid\/cit601","article-title":"Safety of tenofovir during pregnancy for the mother and fetus: A systematic review","volume":"57","author":"Wang","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.01.021","article-title":"Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate","volume":"72","author":"Wen","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3350\/cmh.2020.0049","article-title":"Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop","volume":"26","author":"Yim","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.15585\/mmwr.mm6439a6","article-title":"Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers","volume":"64","author":"Schillie","year":"2015","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","article-title":"Hepatitis B virus infection in children and adolescents","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/cam4.917","article-title":"Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment","volume":"5","author":"Tajiri","year":"2016","journal-title":"Cancer Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/adc.84.5.381","article-title":"Breast feeding and the risks of viral transmission","volume":"84","author":"Michie","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"ref_83","first-page":"119","article-title":"Medications in the breast-feeding mother","volume":"64","author":"Spencer","year":"2001","journal-title":"Am. Fam. Physician"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00514-10","article-title":"Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d\u2019Ivoire, in the ANRS 12109 TEmAA Study, Step 2","volume":"55","author":"Benaboud","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/QAI.0b013e3182a921eb","article-title":"Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life","volume":"65","author":"Mirochnick","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Mugwanya, K.K., Hendrix, C.W., Mugo, N.R., Marzinke, M., Katabira, E.T., Ngure, K., Semiyaga, N.B., John-Stewart, G., Muwonge, T.R., and Muthuri, G. (2016). Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002132"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpediatrics.2011.72","article-title":"Breastfeeding of newborns by mothers carrying hepatitis B virus: A meta-analysis and systematic review","volume":"165","author":"Shi","year":"2011","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17425255.2020.1738384","article-title":"Tenofovir alafenamide use in pregnant and lactating women living with HIV","volume":"16","author":"Eke","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/11\/2320\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:08:09Z","timestamp":1760162889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/11\/2320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":88,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["jcm10112320"],"URL":"https:\/\/doi.org\/10.3390\/jcm10112320","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]}}}